Article

The State Struggle: Paying for Excessively Priced Drugs

High-priced treatments continue to crush state budgets. With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country.

High-priced treatments continue to crush state budgets. California, for example, has set aside $300 million to pay for new hepatitis C drugs. But unfortunately, that cost is just the tip of the iceberg, according to an article from The Fresno Bee.

With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country. There’s the “impossible math” around how to afford hepatitis treatment in Rhode Island, as Rhode Island Public Radio reported. The state’s prison healthcare budget of $19 million must somehow pay for a hep C drug that will cost $150,000 for a round of treatment.

Read more at AHIP Coverage: http://bit.ly/1AUSgi9

Related Videos
Eboni Price-Haywood, MD, and Toni Flowers, PhD
Tom Belmon, CAP, GPBCH
CK Wang, MD, COTA
John Barkett, MBA
1 expert in this video
1 expert in this video
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo